nodes	percent_of_prediction	percent_of_DWPC	metapath
Bacitracin—A2M—HDL-mediated lipid transport—APOE—psoriasis	0.0443	0.126	CbGpPWpGaD
Bacitracin—Albuminuria—Calcitriol—psoriasis	0.0404	0.0623	CcSEcCtD
Bacitracin—IDE—Alzheimers Disease—APOE—psoriasis	0.0356	0.101	CbGpPWpGaD
Bacitracin—A2M—Rho GTPase cycle—TAGAP—psoriasis	0.035	0.0995	CbGpPWpGaD
Bacitracin—Azotaemia—Cyclosporine—psoriasis	0.0268	0.0413	CcSEcCtD
Bacitracin—Azotaemia—Mycophenolate mofetil—psoriasis	0.0261	0.0403	CcSEcCtD
Bacitracin—A2M—Lipoprotein metabolism—APOE—psoriasis	0.0255	0.0724	CbGpPWpGaD
Bacitracin—Albuminuria—Mycophenolic acid—psoriasis	0.0236	0.0365	CcSEcCtD
Bacitracin—Pain—Calcipotriol—psoriasis	0.0232	0.0358	CcSEcCtD
Bacitracin—A2M—Hemostasis—SERPINB8—psoriasis	0.0208	0.0591	CbGpPWpGaD
Bacitracin—Albuminuria—Mycophenolate mofetil—psoriasis	0.0187	0.0288	CcSEcCtD
Bacitracin—A2M—IL6-mediated signaling events—CRP—psoriasis	0.0182	0.0517	CbGpPWpGaD
Bacitracin—Rash—Calcipotriol—psoriasis	0.0171	0.0264	CcSEcCtD
Bacitracin—Pain—Tazarotene—psoriasis	0.0171	0.0264	CcSEcCtD
Bacitracin—Dermatitis—Calcipotriol—psoriasis	0.0171	0.0264	CcSEcCtD
Bacitracin—A2M—Lipid and lipoprotein metabolism—APOE—psoriasis	0.0169	0.0481	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—TNF—psoriasis	0.0165	0.0468	CbGpPWpGaD
Bacitracin—Azotaemia—Methotrexate—psoriasis	0.0148	0.0228	CcSEcCtD
Bacitracin—IDE—Alzheimers Disease—TP53—psoriasis	0.0145	0.0413	CbGpPWpGaD
Bacitracin—Pain—Clobetasol propionate—psoriasis	0.0145	0.0224	CcSEcCtD
Bacitracin—A2M—IL6-mediated signaling events—TYK2—psoriasis	0.0136	0.0386	CbGpPWpGaD
Bacitracin—Pain—Beclomethasone—psoriasis	0.0132	0.0204	CcSEcCtD
Bacitracin—Pain—Fluocinonide—psoriasis	0.0131	0.0202	CcSEcCtD
Bacitracin—Rash—Tazarotene—psoriasis	0.0126	0.0195	CcSEcCtD
Bacitracin—Dermatitis—Tazarotene—psoriasis	0.0126	0.0194	CcSEcCtD
Bacitracin—A2M—IL6-mediated signaling events—JUN—psoriasis	0.011	0.0312	CbGpPWpGaD
Bacitracin—Rash—Clobetasol propionate—psoriasis	0.0107	0.0165	CcSEcCtD
Bacitracin—Dermatitis—Clobetasol propionate—psoriasis	0.0107	0.0165	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—ITGAL—psoriasis	0.0102	0.0289	CbGpPWpGaD
Bacitracin—Rash—Beclomethasone—psoriasis	0.00974	0.015	CcSEcCtD
Bacitracin—Dermatitis—Beclomethasone—psoriasis	0.00973	0.015	CcSEcCtD
Bacitracin—Rash—Fluocinonide—psoriasis	0.00965	0.0149	CcSEcCtD
Bacitracin—Dermatitis—Fluocinonide—psoriasis	0.00964	0.0149	CcSEcCtD
Bacitracin—A2M—IL6-mediated signaling events—STAT3—psoriasis	0.0095	0.027	CbGpPWpGaD
Bacitracin—Pain—Calcitriol—psoriasis	0.00921	0.0142	CcSEcCtD
Bacitracin—Nausea—Beclomethasone—psoriasis	0.00917	0.0142	CcSEcCtD
Bacitracin—Pain—Acitretin—psoriasis	0.00819	0.0126	CcSEcCtD
Bacitracin—Pain—Fluocinolone Acetonide—psoriasis	0.00817	0.0126	CcSEcCtD
Bacitracin—Rash—Methoxsalen—psoriasis	0.00762	0.0117	CcSEcCtD
Bacitracin—Dermatitis—Methoxsalen—psoriasis	0.00761	0.0117	CcSEcCtD
Bacitracin—Nausea—Methoxsalen—psoriasis	0.00717	0.0111	CcSEcCtD
Bacitracin—Vomiting—Calcitriol—psoriasis	0.00684	0.0106	CcSEcCtD
Bacitracin—Rash—Calcitriol—psoriasis	0.00679	0.0105	CcSEcCtD
Bacitracin—Dermatitis—Calcitriol—psoriasis	0.00678	0.0105	CcSEcCtD
Bacitracin—A2M—IL6-mediated signaling events—IL6—psoriasis	0.00664	0.0189	CbGpPWpGaD
Bacitracin—Pain—Hydroxyurea—psoriasis	0.00643	0.00992	CcSEcCtD
Bacitracin—Nausea—Calcitriol—psoriasis	0.00639	0.00986	CcSEcCtD
Bacitracin—A2M—Platelet degranulation—VEGFA—psoriasis	0.00627	0.0178	CbGpPWpGaD
Bacitracin—Vomiting—Acitretin—psoriasis	0.00609	0.00939	CcSEcCtD
Bacitracin—Vomiting—Fluocinolone Acetonide—psoriasis	0.00607	0.00937	CcSEcCtD
Bacitracin—Rash—Acitretin—psoriasis	0.00604	0.00931	CcSEcCtD
Bacitracin—A2M—Hemostasis—ITGAL—psoriasis	0.00603	0.0172	CbGpPWpGaD
Bacitracin—Dermatitis—Acitretin—psoriasis	0.00603	0.00931	CcSEcCtD
Bacitracin—Rash—Fluocinolone Acetonide—psoriasis	0.00602	0.00929	CcSEcCtD
Bacitracin—Dermatitis—Fluocinolone Acetonide—psoriasis	0.00602	0.00928	CcSEcCtD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	0.00598	0.017	CbGpPWpGaD
Bacitracin—Nausea—Acitretin—psoriasis	0.00569	0.00878	CcSEcCtD
Bacitracin—Nausea—Fluocinolone Acetonide—psoriasis	0.00567	0.00875	CcSEcCtD
Bacitracin—A2M—Metabolism—NDUFA5—psoriasis	0.00543	0.0154	CbGpPWpGaD
Bacitracin—Pain—Mycophenolic acid—psoriasis	0.00539	0.00831	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.00506	0.0144	CbGpPWpGaD
Bacitracin—Vomiting—Hydroxyurea—psoriasis	0.00478	0.00737	CcSEcCtD
Bacitracin—Rash—Hydroxyurea—psoriasis	0.00474	0.00731	CcSEcCtD
Bacitracin—Dermatitis—Hydroxyurea—psoriasis	0.00474	0.00731	CcSEcCtD
Bacitracin—A2M—Metabolism—CYP2S1—psoriasis	0.00462	0.0131	CbGpPWpGaD
Bacitracin—Nausea—Hydroxyurea—psoriasis	0.00447	0.00689	CcSEcCtD
Bacitracin—Pain—Cyclosporine—psoriasis	0.00436	0.00672	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—HCAR2—psoriasis	0.00427	0.0121	CbGpPWpGaD
Bacitracin—Pain—Mycophenolate mofetil—psoriasis	0.00425	0.00656	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—ICAM1—psoriasis	0.0042	0.0119	CbGpPWpGaD
Bacitracin—Vomiting—Mycophenolic acid—psoriasis	0.004	0.00618	CcSEcCtD
Bacitracin—Rash—Mycophenolic acid—psoriasis	0.00397	0.00613	CcSEcCtD
Bacitracin—Dermatitis—Mycophenolic acid—psoriasis	0.00397	0.00612	CcSEcCtD
Bacitracin—Pain—Prednisolone—psoriasis	0.00396	0.00612	CcSEcCtD
Bacitracin—Pain—Hydrocortisone—psoriasis	0.00387	0.00597	CcSEcCtD
Bacitracin—Nausea—Mycophenolic acid—psoriasis	0.00374	0.00577	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—TAGAP—psoriasis	0.0037	0.0105	CbGpPWpGaD
Bacitracin—Pain—Triamcinolone—psoriasis	0.00365	0.00562	CcSEcCtD
Bacitracin—Pain—Betamethasone—psoriasis	0.00331	0.0051	CcSEcCtD
Bacitracin—Pain—Dexamethasone—psoriasis	0.00331	0.0051	CcSEcCtD
Bacitracin—Vomiting—Cyclosporine—psoriasis	0.00324	0.005	CcSEcCtD
Bacitracin—Rash—Cyclosporine—psoriasis	0.00321	0.00496	CcSEcCtD
Bacitracin—Dermatitis—Cyclosporine—psoriasis	0.00321	0.00495	CcSEcCtD
Bacitracin—Vomiting—Mycophenolate mofetil—psoriasis	0.00316	0.00487	CcSEcCtD
Bacitracin—Rash—Mycophenolate mofetil—psoriasis	0.00313	0.00483	CcSEcCtD
Bacitracin—Dermatitis—Mycophenolate mofetil—psoriasis	0.00313	0.00483	CcSEcCtD
Bacitracin—Nausea—Cyclosporine—psoriasis	0.00303	0.00467	CcSEcCtD
Bacitracin—Nausea—Mycophenolate mofetil—psoriasis	0.00295	0.00455	CcSEcCtD
Bacitracin—Rash—Prednisolone—psoriasis	0.00292	0.00451	CcSEcCtD
Bacitracin—Dermatitis—Prednisolone—psoriasis	0.00292	0.0045	CcSEcCtD
Bacitracin—Vomiting—Hydrocortisone—psoriasis	0.00288	0.00444	CcSEcCtD
Bacitracin—Rash—Hydrocortisone—psoriasis	0.00285	0.0044	CcSEcCtD
Bacitracin—Dermatitis—Hydrocortisone—psoriasis	0.00285	0.0044	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.00278	0.00791	CbGpPWpGaD
Bacitracin—Nausea—Prednisolone—psoriasis	0.00275	0.00425	CcSEcCtD
Bacitracin—Vomiting—Triamcinolone—psoriasis	0.00271	0.00418	CcSEcCtD
Bacitracin—Nausea—Hydrocortisone—psoriasis	0.00269	0.00415	CcSEcCtD
Bacitracin—Rash—Triamcinolone—psoriasis	0.00269	0.00415	CcSEcCtD
Bacitracin—Dermatitis—Triamcinolone—psoriasis	0.00269	0.00414	CcSEcCtD
Bacitracin—Nausea—Triamcinolone—psoriasis	0.00253	0.00391	CcSEcCtD
Bacitracin—A2M—Hemostasis—NOS2—psoriasis	0.00248	0.00704	CbGpPWpGaD
Bacitracin—Vomiting—Betamethasone—psoriasis	0.00246	0.00379	CcSEcCtD
Bacitracin—Vomiting—Dexamethasone—psoriasis	0.00246	0.00379	CcSEcCtD
Bacitracin—Rash—Dexamethasone—psoriasis	0.00244	0.00376	CcSEcCtD
Bacitracin—Rash—Betamethasone—psoriasis	0.00244	0.00376	CcSEcCtD
Bacitracin—Dermatitis—Betamethasone—psoriasis	0.00244	0.00376	CcSEcCtD
Bacitracin—Dermatitis—Dexamethasone—psoriasis	0.00244	0.00376	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.00242	0.00688	CbGpPWpGaD
Bacitracin—Pain—Methotrexate—psoriasis	0.00241	0.00371	CcSEcCtD
Bacitracin—Nausea—Dexamethasone—psoriasis	0.0023	0.00354	CcSEcCtD
Bacitracin—Nausea—Betamethasone—psoriasis	0.0023	0.00354	CcSEcCtD
Bacitracin—A2M—Metabolism—CARM1—psoriasis	0.00225	0.00641	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCL20—psoriasis	0.00222	0.0063	CbGpPWpGaD
Bacitracin—Vomiting—Prednisone—psoriasis	0.00214	0.0033	CcSEcCtD
Bacitracin—Rash—Prednisone—psoriasis	0.00212	0.00328	CcSEcCtD
Bacitracin—Dermatitis—Prednisone—psoriasis	0.00212	0.00327	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.00211	0.00599	CbGpPWpGaD
Bacitracin—Nausea—Prednisone—psoriasis	0.002	0.00309	CcSEcCtD
Bacitracin—Vomiting—Methotrexate—psoriasis	0.00179	0.00276	CcSEcCtD
Bacitracin—Rash—Methotrexate—psoriasis	0.00178	0.00274	CcSEcCtD
Bacitracin—Dermatitis—Methotrexate—psoriasis	0.00177	0.00274	CcSEcCtD
Bacitracin—Nausea—Methotrexate—psoriasis	0.00167	0.00258	CcSEcCtD
Bacitracin—A2M—Hemostasis—VEGFA—psoriasis	0.00143	0.00408	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CAT—psoriasis	0.00139	0.00394	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SOCS1—psoriasis	0.00122	0.00347	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TP53—psoriasis	0.00108	0.00308	CbGpPWpGaD
Bacitracin—A2M—Metabolism—APOE—psoriasis	0.00108	0.00306	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PPARG—psoriasis	0.000938	0.00267	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—APOE—psoriasis	0.000901	0.00256	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—LEP—psoriasis	0.000901	0.00256	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NFKBIA—psoriasis	0.000839	0.00239	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TYK2—psoriasis	0.000688	0.00195	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CXCL8—psoriasis	0.000599	0.0017	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JUN—psoriasis	0.000557	0.00158	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NFKB1—psoriasis	0.000536	0.00152	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFA—psoriasis	0.000486	0.00138	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—STAT3—psoriasis	0.000481	0.00137	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TP53—psoriasis	0.000367	0.00104	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IL6—psoriasis	0.000336	0.000956	CbGpPWpGaD
